SEARCH

SEARCH BY CITATION

References

  • 1
    Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244:359362.MEDLINE
  • 2
    Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, Hu PY, et al. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team [see Comments]. N Engl J Med 1992; 327:18991905.MEDLINE
  • 3
    Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, Furuta S, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12:671675.MEDLINE
  • 4
    Tremolada F, Casarin C, Alberti A, Drago C, Tagger A, Ribero ML, Realdi G. Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis. J Hepatol 1992; 16:273281.MEDLINE
  • 5
    Kanai K, Kako M, Kumada T, Tsubouchi H, Aikawa T, Kojima M, Harada H, et al. High-dose (9 MU) long-term (60 weeks) alfa-interferon therapy for chronic hepatitis patients infected with HCV genotype 1b. Arch Virol 1998; 143:15451554.MEDLINE
  • 6
    . Heathcote EJ, James S, Mullen KD, Hauser SC, Rosenblate H, Albert DG, Jr. Chronic hepatitis C virus patients with breakthroughs during interferon treatment can successfully be retreated with consensus interferon. The Consensus Interferon Study Group. Hepatology 1999; 30:562566.MEDLINE
  • 7
    Lee WM, Reddy KR, Tong MJ, Black M, van Leeuwen DJ, Hollinger FB, Mullen KD, et al. Early hepatitis C virus-RNA responses predict interferon treatment outcomes in chronic hepatitis C. The Consensus Interferon Study Group. Hepatology 1998; 28:14111415.MEDLINE
  • 8
    Justesen J, Hartmann R, Kjeldgaard NO. Gene structure and function of the 2′-5′-oligoadenylate synthetase family. Cell Mol Life Sci 2000; 57:15931612.MEDLINE
  • 9
    Kuhen KL, Vessey JW, Samuel CE. Mechanism of interferon action: identification of essential positions within the novel 15-base-pair KCS element required for transcriptional activation of the RNA-dependent protein kinase pkr gene. J Virol 1998; 72:99349939.MEDLINE
  • 10
    Kuhen KL, Samuel CE. Mechanism of interferon action: functional characterization of positive and negative regulatory domains that modulate transcriptional activation of the human RNA-dependent protein kinase Pkr promoter. Virology 1999; 254:182195.MEDLINE
  • 11
    Thomis DC, Samuel CE. Mechanism of interferon action: evidence for intermolecular autophosphorylation and autoactivation of the interferon-induced, RNA-dependent protein kinase PKR. J Virol 1993; 67:76957700.MEDLINE
  • 12
    Lu J, O'Hara EB, Trieselmann BA, Romano PR, Dever TE. The interferon-induced double-stranded RNA-activated protein kinase PKR will phosphorylate serine, threonine, or tyrosine at residue 51 in eukaryotic initiation factor 2alpha. J Biol Chem 1999; 274:3219832203.MEDLINE
  • 13
    Tsukiyama-Kohara K, Iizuka N, Kohara M, Nomoto A. Internal ribosome entry site within hepatitis C virus RNA. J Virol 1992; 66:14761483.MEDLINE
  • 14
    Wang C, Sarnow P, Siddiqui A. Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism. J Virol 1993; 67:33383344.MEDLINE
  • 15
    Reynolds JE, Kaminski A, Kettinen HJ, Grace K, Clarke BE, Carroll AR, Rowlands DJ, et al. Unique features of internal initiation of hepatitis C virus RNA translation. EMBO J 1995; 14:60106020.MEDLINE
  • 16
    Lu HH, Wimmer E. Poliovirus chimeras replicating under the translational control of genetic elements of hepatitis C virus reveal unusual properties of the internal ribosomal entry site of hepatitis C virus. Proc Natl Acad Sci U S A 1996; 93:14121417.MEDLINE
  • 17
    Honda M, Ping LH, Rijnbrand RC, Amphlett E, Clarke B, Rowlands D, Lemon SM. Structural requirements for initiation of translation by internal ribosome entry within genome-length hepatitis C virus RNA. Virology 1996; 222:3142.MEDLINE
  • 18
    Wang C, Sarnow P, Siddiqui A. A conserved helical element is essential for internal initiation of translation of hepatitis C virus RNA. J Virol 1994; 68:73017307.MEDLINE
  • 19
    Wang C, Le SY, Ali N, Siddiqui A. An RNA pseudoknot is an essential structural element of the internal ribosome entry site located within the hepatitis C virus 5′ noncoding region. RNA 1995; 1:526537.MEDLINE
  • 20
    Rijnbrand RC, Abbink TE, Haasnoot PC, Spaan WJ, Bredenbeek PJ. The influence of AUG codons in the hepatitis C virus 5–nontranslated region on translation and mapping of the translation initiation window. Virology 1996; 226:4756.MEDLINE
  • 21
    Honda M, Brown EA, Lemon SM. Stability of a stem-loop involving the initiator AUG controls the efficiency of internal initiation of translation on hepatitis C virus RNA. RNA 1996; 2:955968.MEDLINE
  • 22
    Honda M, Beard MR, Ping LH, Lemon SM. A phylogenetically conserved stem-loop structure at the 5′ border of the internal ribosome entry site of hepatitis C virus is required for cap-independent viral translation. J Virol 1999; 73:11651174.MEDLINE
  • 23
    Buratti E, Tisminetzky S, Zotti M, Baralle FE. Functional analysis of the interaction between HCV 5′UTR and putative subunits of eukaryotic translation initiation factor eIF3. Nucleic Acids Res 1998; 26:31793187.MEDLINE
  • 24
    Sizova DV, Kolupaeva VG, Pestova TV, Shatsky IN, Hellen CU. Specific interaction of eukaryotic translation initiation factor 3 with the 5′ nontranslated regions of hepatitis C virus and classical swine fever virus RNAs. J Virol 1998; 72:47754782.MEDLINE
  • 25
    Ali N, Siddiqui A. The La antigen binds 5′ noncoding region of the hepatitis C virus RNA in the context of the initiator AUG codon and stimulates internal ribosome entry site-mediated translation. Proc Natl Acad Sci U S A 1997; 94:22492254.MEDLINE
  • 26
    Isoyama T, Kamoshita N, Yasui K, Iwai A, Shiroki K, Toyoda H, Yamada A, et al. Lower concentration of La protein required for internal ribosome entry on hepatitis C virus RNA than on poliovirus RNA. J Gen Virol 1999; 80:23192327.MEDLINE
  • 27
    Spangberg K, Goobar-Larsson L, Wahren-Herlenius M, Schwartz S. The La protein from human liver cells interacts specifically with the U-rich region in the hepatitis C virus 3′ untranslated region. J Hum Virol 1999; 2:296307.MEDLINE
  • 28
    Ali N, Pruijn GJ, Kenan DJ, Keene JD, Siddiqui A. Human La antigen is required for the hepatitis C virus internal ribosome entry site–mediated translation. J Biol Chem 2000; 275:2753127540.MEDLINE
  • 29
    Spangberg K, Wiklund L, Schwartz S. Binding of the La autoantigen to the hepatitis C virus 3– untranslated region protects the RNA from rapid degradation in vitro. J Gen Virol 2001; 82:113120.MEDLINE
  • 30
    Anwar A, Ali N, Tanveer R, Siddiqui A. Demonstration of functional requirement of polypyrimidine tract-binding protein by SELEX RNA during hepatitis C virus internal ribosome entry site–mediated translation initiation [In Process Citation]. J Biol Chem 2000; 275:3423134235.MEDLINE
  • 31
    Ito T, Lai MM. An internal polypyrimidine-tract-binding protein-binding site in the hepatitis C virus RNA attenuates translation, which is relieved by the 3′-untranslated sequence. Virology 1999; 254:288296.MEDLINE
  • 32
    Ali N, Siddiqui A. Interaction of polypyrimidine tract-binding protein with the 5′ noncoding region of the hepatitis C virus RNA genome and its functional requirement in internal initiation of translation. J Virol 1995; 69:63676375.MEDLINE
  • 33
    Honda M, Kaneko S, Matsushita E, Kobayashi K, Abell GA, Lemon SM. Cell cycle regulation of hepatitis C virus internal ribosomal entry site–directed translation. Gastroenterology 2000; 118:152162.MEDLINE
  • 34
    Davis S, Watson JC. In vitro activation of the interferon-induced, double-stranded RNA-dependent protein kinase PKR by RNA from the 3′ untranslated regions of human alpha-tropomyosin. Proc Natl Acad Sci 1996; 93:508513.MEDLINE
  • 35
    Honda M, Kaneko S, Kawai H, Shirota Y, Kobayashi K. Differential gene expression between chronic hepatitis B and C hepatic lesions. Gastroenterology 2001; 120:955966.MEDLINE
  • 36
    Pruijn GJ, Thijssen JP, Smith PR, Williams DG, Van Venrooij WJ. Anti-La monoclonal antibodies recognizing epitopes within the RNA-binding domain of the La protein show differential capacities to immunoprecipitate RNA-associated La protein. Eur J Biochem 1995; 232:611619.MEDLINE
  • 37
    Toyoda H, Koide N, Kamiyama M, Tobita K, Mizumoto K, Imura N. Host factors required for internal initiation of translation on poliovirus RNA. Arch Virol 1994; 138:115.MEDLINE
  • 38
    Rumin S, Berthillon P, Tanaka E, Kiyosawa K, Trabaud MA, Bizollon T, Gouillat C, et al. Dynamic analysis of hepatitis C virus replication and quasispecies selection in long-term cultures of adult human hepatocytes infected in vitro. J Gen Virol 1999; 80:30073018.MEDLINE
  • 39
    Negro F, Giostra E, Krawczynski K, Quadri R, Rubbia-Brandt L, Mentha G, Colucci G, et al. Detection of intrahepatic hepatitis C virus replication by strand-specific semi-quantitative RT-PCR: preliminary application to the liver transplantation model. J Hepatol 1998; 29:111.MEDLINE
  • 40
    Takizawa T, Tatematsu C, Nakanishi Y. Double-stranded RNA-activated protein kinase (PKR) fused to green fluorescent protein induces apoptosis of human embryonic kidney cells: possible role in the Fas signaling pathway. J Biochem (Tokyo) 1999; 125:391398.MEDLINE
  • 41
    Desai SY, Sen GC. Effects of varying lengths of double-stranded RNA on binding and activation of 2′-5′-oligoadenylate synthetase. J Interferon Cytokine Res 1997; 17:531536.MEDLINE
  • 42
    Yen JH, Chang SC, Hu CR, Chu SC, Lin SS, Hsieh YS, Chang MF. Cellular proteins specifically bind to the 5′-noncoding region of hepatitis C virus RNA. Virology 1995; 208:723732.MEDLINE
  • 43
    Meerovitch K, Svitkin YV, Lee HS, Lejbkowicz F, Kenan DJ, Chan EK, Agol VI, et al. La autoantigen enhances and corrects aberrant translation of poliovirus RNA in reticulocyte lysate. J Virol 1993; 67:3798807.MEDLINE
  • 44
    Pogue GP, Hofmann J, Duncan R, Best JM, Etherington J, Sontheimer RD, Nakhasi HL. Autoantigens interact with cis-acting elements of rubella virus RNA. J Virol 1996; 70:62696277.MEDLINE
  • 45
    Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244:362364.MEDLINE
  • 46
    Ghadge GD, Swaminathan S, Katze MG, Thimmapaya B. Binding of the adenovirus VAI RNA to the interferon-induced 68-kDa protein kinase correlates with function. Proc Natl Acad Sci 1991; 88:71407144.MEDLINE
  • 47
    Sharp TV, Schwemmle M, Jeffrey I, Laing K, Mellor H, Proud CG, Hilse K et al. Comparative analysis of the regulation of the interferon-inducible protein kinase PKR by Epstein-Barr virus RNAs EBER-1 and EBER-2 and adenovirus VAI RNA. Nucleic Acids Res 1993; 21:44834490.MEDLINE
  • 48
    James MC, Jeffrey IW, Pruijn GJ, Thijssen JP, Clemens MJ. Translational control by the La antigen. Structure requirements for rescue of the double-stranded RNA-mediated inhibition of protein synthesis. Eur J Biochem 1999; 266:151162.MEDLINE
  • 49
    Xiao Q, Sharp TV, Jeffrey IW, James MC, Pruijn GJ, van Venrooij WJ, Clemens MJ. The La antigen inhibits the activation of the interferon-inducible protein kinase PKR by sequestering and unwinding double-stranded RNA. Nucleic Acids Res 1994; 22:25122518.MEDLINE
  • 50
    Rutjes SA, Utz PJ, van der Heijden A, Broekhuis C, van Venrooij WJ, Pruijn GJ. The La (SS-B) autoantigen, a key protein in RNA biogenesis, is dephosphorylated and cleaved early during apoptosis. Cell Death Differ 1999; 6:976986.MEDLINE
  • 51
    Shiroki K, Isoyama T, Kuge S, Ishii T, Ohmi S, Hata S, Suzuki K, et al. Intracellular redistribution of truncated La protein produced by poliovirus 3Cpro-mediated cleavage. J Virol 1999; 73:21932200.MEDLINE